Jeffrey D. Capello

Executive Vice President & Chief Financial Officer at Biogen, Inc.

Jeffrey D. Capello

Jeffrey D. Capello

Executive Vice President & Chief Financial Officer at Biogen, Inc.

Career Highlights

Biogen, Inc.
Ortho-Clinical Diagnostics, Inc.
Beacon Health Options, Inc. (Virginia)

RelSci Relationships


Number of Boards






Number of Awards


RelSci Relationships are individuals Jeffrey D. Capello likely has professional access to. A relationship does not necessarily indicate a personal connection.

Senior Advisor at L.E.K. Consulting LLC

Relationship likelihood: Strong

Co-Founder & General Partner at Longwood Fund Management LLC

Relationship likelihood: Strong

Chief Executive Officer at Biogen, Inc.

Relationship likelihood: Strong

Chairman of the Board, Co-Founder at Concert Pharmaceuticals, Inc.

Relationship likelihood: Strong

Professor at Harvard University

Relationship likelihood: Strong

Professor at The Rockefeller University

Relationship likelihood: Strong

Executive Vice President & Chief Human Resources Officer at Biogen, Inc.

Relationship likelihood: Strong

Partner at Bessemer Venture Partners

Relationship likelihood: Strong

Executive Vice President, Global Product Strategy & Commercialization at Biogen, Inc.

Relationship likelihood: Strong

Former Chief Executive Officer at Ivenix, Inc.

Relationship likelihood: Strong

Paths to Jeffrey D. Capello
Potential Connections via
Relationship Science
Jeffrey D. Capello
Executive Vice President & Chief Financial Officer at Biogen, Inc.
BS in Business Administration

Founded in 1791, University of Vermont is the fifth oldest university in New England (after Harvard, Yale, Dartmouth and Brown). UVM is fully accredited by the New England Association of Schools and Colleges (NEASC). Called UVM for Universitas Viridis Montis, Latin for "University of the Green Mountains."


Harvard Business School (HBS) is the graduate business school of Harvard University in Boston, Massachusetts, United States. The school offers a large full-time MBA program, doctoral programs, and many executive education programs. It owns Harvard Business School Publishing, which publishes business books, leadership articles, online management tools for corporate learning, case studies, and the monthly Harvard Business Review.

Career History
Executive Vice President & Chief Financial Officer
2017 - 2020

Biogen has some of the world’s best neurologists and neuroscientists. They engage with physicians and scientific leaders around the world with the aim to further medical research. Their focus on neuroscience, their deep scientific expertise and courage to take risks makes them leaders in the research and development of medicines to transform neuroscience to benefit society. Their technology and engineering capabilities create novel ways to seamlessly transition products from development to manufacturing with the intent of bringing their high-quality medicines to market faster. They respect the contributions of health care providers caring for people living with neurological diseases. They honor the important role of caregivers, families and friends who care about them.

Chief Financial Officer & Executive Vice President
2014 - 2015

Ortho-Clinical Diagnostics, Inc. engages in the manufacture and design of diagnostic, transfusion, clinical equipment, and systems. It provides solutions for screening, diagnosing, monitoring, and confirming diseases early before they put lives at risk. Its products include instrument systems and reagents that screen for AIDS and hepatitis C, as well as blood typing systems. The company was founded in 1939 and is headquartered in Raritan, NJ.

Chief Financial Officer & Executive Vice President
Prior - 2017

Beacon Health Options provides managed behavioral health care services. It offers solutions to employer groups, health plans, and government agencies. The firm specializes in managed behavioral health and disease management programs for commercial, Medicare and Medicaid products. The company is headquartered in Chesapeake, VA.

Boards & Committees
Member, Board of Directors
2008 - 2008

Sirtris Pharmaceuticals, Inc., a GSK company, is developing small molecule drugs that target the sirtuins, a family of seven enzymes associated with diseases of aging. Modulation of these enzymes offers the promise of drug discovery in multiple therapeutic areas.Sirtris was one of the pharmaceutical companies focused on the sirtuin platform and remains the innovative drug discovery. Preclinical research indicates that the sirtuins play important roles in pathways for multiple diseases of aging, including Type 2 Diabetes, as well as neurodegenerative, cardiovascular and inflammatory diseases.Sirtris researchers are working to translate this research into a potential new class of pharmaceuticals to treat diseases of aging, offering the ability for people to live longer, healthier lives. Sirtris has focused on developing many novel small molecule activators of SIRT1, the most studied member of the sirtuin family. These new chemical entities or NCEs are novel compounds that are chemically unrelated to resveratrol, a naturally occurring compound that was used as an early proof-of-concept for SIRT1 activation. Besides being structurally differentiated from resveratrol, the NCEs are more specific for the target SIRT1 and have improved drug-like properties. The company has completed several early stage translational clinical studies with the first generation NCEs and has several active clinical trials under way. Sirtris operates as an independent Discovery Performance Unit (DPU) within GSK and is located in Technology Square, Cambridge, Mass.Sirtris' culture mixes scientific curiosity with a dynamic, fast-paced environment, resembling its biotech roots while harnessing all of GSK's broad discovery, development, and commercialization capabilities. The company was founded in 2004 and is headquartered in Cambridge, MA.

Public Holdings
Restricted data only for RelSci Professional users.
Awards & Honors
CPA (Certified Public Accountant)
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Jeffrey D. Capello. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Jeffrey D. Capello's profile does not indicate a business or promotional relationship of any kind between RelSci and Jeffrey D. Capello.